Completeness of circle of Willis and white matter hyperintensities in patients with severe internal carotid artery stenosis
- 21 Downloads
We investigated whether completeness of the circle of Willis (CoW) protected patients with severe internal carotid artery (ICA) stenosis against white matter hyperintensities (WMHs).
We included 115 patients with unilateral ICA stenosis ≥ 70%. The completeness of CoW was assessed and WMHs were rated on a visual scale. The score of deep and periventricular WMHs was compared between patients with complete and incomplete CoW and between the two hemispheres, ipsilateral and contralateral to stenosed ICA.
We included 115 patients with severe ICA stenosis, 60 patients had a complete CoW (52.17%) and 55 had an incomplete CoW (47.83%). The patients with incomplete CoW had higher score of deep WMHs (OR = 1.82, 95% CI 1.08–3.06, P = 0.023) and periventricular WMHs (OR = 4.53, 95% CI 2.09–9.81, P = 0.000) than those with complete CoW. In the patients with incomplete CoW, the score of deep WMHs (OR = 4.14, 95% CI 1.33–12.93, P = 0.014) and periventricular WMHs (OR = 5.46, 95% CI 1.16–25.62, P = 0.032) was higher in the hemisphere ipsilateral to stenosed ICA than that in the contralateral hemisphere. In the patients with complete CoW, there was no significant difference in the score of deep WMHs (OR = 2.10, 95% CI 0.37–11.91, P = 0.401) and periventricular WMHs (OR = 2.83, 95% CI 0.99–8.05, P = 0.051) between the ipsilateral and contralateral hemispheres to stenosed ICA.
The completeness of CoW protected patients with severe ICA stenosis against WMHs.
KeywordsCircle of Willis White matter hyperintensities Internal carotid artery stenosis
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Smith EE, Saposnik G, Biessels GJ, Doubal FN, Fornage M, Gorelick PB, Greenberg SM, Higashida RT, Kasner SE, Seshadri S, American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Functional Genomics and Translational Biology; and Council on Hypertension (2017) Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 48:e44–e71PubMedGoogle Scholar
- 5.The LADIS Study Group, Poggesi A, Pantoni L, Inzitari D, Fazekas F, Ferro J, O'Brien J, Hennerici M, Scheltens P, Erkinjuntti T, Visser M, Langhorne P, Chabriat H, Waldemar G, Wallin A, Wahlund A (2011) 2001-2011: a decade of the LADIS (Leukoaraiosis and disability) study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis 32:577–588CrossRefGoogle Scholar
- 6.Ben-Assayag E, Mijajlovic M, Shenhar-Tsarfaty S, Bova I, Shopin L, Bornstein NM (2012) Leukoaraiosis is a chronic atherosclerotic disease. Sci World J 2012:6. https://doi.org/10.1100/2012/532141
- 10.Hoksbergen AW, Majoie CB, Hulsmans FJ, Legemate DA (2013) Assessment of the collateral function of the circle of Willis: three-dimensional time-of-flight MR angiography compared with transcranial color coded duplex sonography. Am J Neuroradiol 24:456–462Google Scholar
- 13.King KS, Peshock RM, Warren MW, Alhilali L, Hulsey K, McColl R, Weiner MF, Ayers C, Whittemore A (2013) Evaluation of a practical visual MRI rating scale of brain white matter hyperintensities for clinicians based on largest lesion size regardless of location. AJNR Am J Neuroradiol 34:797–801CrossRefGoogle Scholar
- 14.Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge R, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M, STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1) (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12:822–838CrossRefGoogle Scholar